(1S,4R,9R,10R,11R)-21-(cyclopropylmethyl)-16-methoxy-21-azahexacyclo[9.7.3.25,8.01,10.04,9.013,18]tricosa-6,13(18),14,16-tetraen-3-one

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 吗啡烷
• 英文名称: (1S,4R,9R,10R,11R)-21-(cyclopropylmethyl)-16-methoxy-21-azahexacyclo[9.7.3.25,8.01,10.04,9.013,18]tricosa-6,13(18),14,16-tetraen-3-one
• 化学式: C₂₇H₃₃NO₂
• 分子量: 403.6
• InChiKey: YVEBZCTYNRVSFU-MMQBDCAJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  30
• 可旋转键数：
  3
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• 7,8-Cyclicmorphinan Analogs
  申请人：Purdue Pharma L.P.

  公开号：US20140187571A1

  公开（公告）日：2014-07-03

  The application is directed to compounds of Formula I-A and pharmaceutically acceptable salts and solvates thereof, wherein Cy, R 1a -R 3a , R 4a , and R 4b are defined as set forth in the specification. The invention is also directed to use of compounds of Formula I-A to treat disorders responsive to the modulation of one or more opioid receptors, or as synthetic intermediates. Certain compounds of the present invention are especially useful for treating pain.

  本申请涉及式I-A的化合物以及药用可接受的盐和溶剂化物，其中Cy、R1a-R3a、R4a和R4b的定义如说明书所述。本发明还涉及将式I-A的化合物用于治疗对一或多个阿片受体调节有反应的疾病，或作为合成中间体。本发明中的某些化合物特别适用于治疗疼痛。
• 7,8-CYCLICMORPHINAN ANALOGS
  申请人：Purdue Pharma LP

  公开号：EP2941430B1

  公开（公告）日：2017-04-26
• US8957084B2
  申请人：——

  公开号：US8957084B2

  公开（公告）日：2015-02-17
• [EN] 7,8-CYCLICMORPHINAN ANALOGS<br/>[FR] ANALOGUES DE 7,8-CYCLICMORPHINANE
  申请人：PURDUE PHARMA LP

  公开号：WO2014102587A1

  公开（公告）日：2014-07-03

  The application is directed to compounds of Formula (I), and pharmaceutically acceptable salts and solvates thereof, wherein Cy, R1-R3, R4A, and R4B are defined as set forth in the specification. The invention is also directed to use of compounds of Formula (I) to treat disorders responsive to the modulation of one or more opioid receptors, or as synthetic intermediates. Certain compounds of the present invention are especially useful for treating pain.